578 related articles for article (PubMed ID: 27069355)
1. A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery.
Zou Y; Guo CG; Yang ZG; Sun JH; Zhang MM; Fu CY
Drug Des Devel Ther; 2016; 10():1243-55. PubMed ID: 27069355
[TBL] [Abstract][Full Text] [Related]
2. Transarterial embolization combined with RNA interference targeting hypoxia-inducible factor-1α for hepatocellular carcinoma: a preliminary study of rat model.
Ni JY; Xu LF; Wang WD; Huang QS; Sun HL; Chen YT
J Cancer Res Clin Oncol; 2017 Feb; 143(2):199-207. PubMed ID: 27638772
[TBL] [Abstract][Full Text] [Related]
3. Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro.
Nass N; Streit S; Wybranski C; Jürgens J; Brauner J; Schulz N; Powerski M; Ricke J; Kalinski T; Dudeck O; Seidensticker M
Anticancer Res; 2017 Jan; 37(1):87-93. PubMed ID: 28011478
[TBL] [Abstract][Full Text] [Related]
4. Transarterial Chemoembolization Using Sorafenib in a Rabbit VX2 Liver Tumor Model: Pharmacokinetics and Antitumor Effect.
Kim GM; Kim MD; Kim do Y; Kim SH; Won JY; Park SI; Lee do Y; Shin W; Shin M
J Vasc Interv Radiol; 2016 Jul; 27(7):1086-92. PubMed ID: 27179404
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human hepatocellular carcinoma tumor angiogenesis by siRNA silencing of VEGF via hepatic artery perfusion.
Zou Y; Guo CG; Zhang MM
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4751-61. PubMed ID: 26744866
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolization.
Liao XF; Yi JL; Li XR; Deng W; Yang ZF; Tian G
World J Gastroenterol; 2004 Jul; 10(13):1885-9. PubMed ID: 15222029
[TBL] [Abstract][Full Text] [Related]
7. Hepatic arterial administration of sorafenib and iodized oil effectively attenuates tumor growth and intrahepatic metastasis in rabbit VX2 hepatocellular carcinoma model.
Zhang L; Liu FY; Fu JX; Duan F; Fan QS; Wang MQ
Int J Clin Exp Pathol; 2014; 7(11):7775-81. PubMed ID: 25550815
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of curcumin liposome after transcatheter arterial embolization in VX2 rabbits.
Zhang X; Dai F; Chen J; Xie X; Xu H; Bai C; Qiao W; Shen W
Cancer Biol Ther; 2019; 20(5):642-652. PubMed ID: 30621501
[TBL] [Abstract][Full Text] [Related]
9. siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo.
Raskopf E; Vogt A; Sauerbruch T; Schmitz V
J Hepatol; 2008 Dec; 49(6):977-84. PubMed ID: 18845354
[TBL] [Abstract][Full Text] [Related]
10. The effects of RNA interference mediated VEGF gene silencing on biological behavior of renal cell carcinoma and transplanted renal tumor in nude mice.
Wang Q; Wang S; Sun SQ; Cheng ZH; Zhang Y; Chen G; Gu M; Yao HJ; Wang Z; Zhou J; Peng YB; Xu MX; Zhang K; Sun XW
Cancer Biomark; 2016; 16(1):1-9. PubMed ID: 26484606
[TBL] [Abstract][Full Text] [Related]
11. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.
Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX
Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of transarterial embolization with arsenic trioxide oil emulsion in a rabbit VX2 liver tumor model.
Kim HJ; Shin JH; Kim TH; Kim EY; Park YS; Park CS; Song HY
J Vasc Interv Radiol; 2009 Oct; 20(10):1365-70. PubMed ID: 19713126
[TBL] [Abstract][Full Text] [Related]
13. [Antitumor and anti-angiogenic effects of manumycin on human hepatocellular carcinoma HepG2 xenografts in nude mice].
Zhou JM; Zhu XF; Liu ZC; Fu LW; Yang XP; Liang YJ; Pan QC
Ai Zheng; 2005 Aug; 24(8):935-9. PubMed ID: 16086869
[TBL] [Abstract][Full Text] [Related]
14. [Reduction of tumorigenicity of SMMC7721 hepatoma cell line by VEGF siRNA].
Huang J; Wang HB; Ge SF; Jia RB; Huang QS; Zheng XM
Fen Zi Xi Bao Sheng Wu Xue Bao; 2007 Oct; 40(5):277-85. PubMed ID: 18254331
[TBL] [Abstract][Full Text] [Related]
15. 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP)-formulated, immune-stimulatory vascular endothelial growth factor a small interfering RNA (siRNA) increases antitumoral efficacy in murine orthotopic hepatocellular carcinoma with liver fibrosis.
Kornek M; Lukacs-Kornek V; Limmer A; Raskopf E; Becker U; Klöckner M; Sauerbruch T; Schmitz V
Mol Med; 2008; 14(7-8):365-73. PubMed ID: 18392108
[TBL] [Abstract][Full Text] [Related]
16. Inflammation and cancer: inhibiting the progression of residual hepatic VX2 carcinoma by anti-inflammatory drug after incomplete radiofrequency ablation.
Jiang T; Zhang X; Ding J; Duan B; Lu S
Int J Clin Exp Pathol; 2015; 8(11):13945-56. PubMed ID: 26823706
[TBL] [Abstract][Full Text] [Related]
17. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted magnetic resonance imaging to evaluate microvascular density after transarterial embolization ablation in a rabbit VX2 liver tumor model.
Qian T; Chen M; Gao F; Meng F; Gao X; Yin H
Magn Reson Imaging; 2014 Oct; 32(8):1052-7. PubMed ID: 24970024
[TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma.
Qu K; Yan Z; Wu Y; Chen Y; Qu P; Xu X; Yuan P; Huang X; Xing J; Zhang H; Liu C; Zhang J
J Gastroenterol Hepatol; 2015 May; 30(5):925-32. PubMed ID: 25641377
[TBL] [Abstract][Full Text] [Related]
20. Correlation of hypoxia-inducible factor 1alpha with angiogenesis in liver tumors after transcatheter arterial embolization in an animal model.
Liang B; Zheng CS; Feng GS; Wu HP; Wang Y; Zhao H; Qian J; Liang HM
Cardiovasc Intervent Radiol; 2010 Aug; 33(4):806-12. PubMed ID: 19937023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
